Skip to main content

Adverse effects induced by second-line antituberculosis drugs: an update based on last WHO treatment recommendations for drug-resistant tuberculosis Cover

.blurhash-client-img { display: none !important; }

Adverse effects induced by second-line antituberculosis drugs: an update based on last WHO treatment recommendations for drug-resistant tuberculosis

Volume 70 (2021): Issue 3 (October 2021)

By: Ionela-Alina Grosu-Creangă, Antigona Carmen Trofor, Radu Adrian Crișan-Dabija, Daniela Robu-Popa, Cristina Mihaela Ghiciuc and Elena Cătălina Lupușoru

Open Access

|Oct 2022

Download Article

Download the full article as a PDF file.

Articles in this issue

DOI: https://doi.org/10.2478/pneum-2022-0029 | Journal eISSN: 2247-059X | Journal ISSN: 2067-2993

Journal RSS Feed

Language: English

Page range: 117 - 126

Published on: Oct 21, 2022

Published by: Romanian Society of Pneumology

In partnership with: Paradigm Publishing Services

Publication frequency: Volume open

Keywords:

second-line drugs,

adverse drug effects

Related subjects:

Clinical medicine,

Clinical medicine, other,

Internal medicine,

© 2022 Ionela-Alina Grosu-Creangă, Antigona Carmen Trofor, Radu Adrian Crișan-Dabija, Daniela Robu-Popa, Cristina Mihaela Ghiciuc, Elena Cătălina Lupușoru, published by Romanian Society of Pneumology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Volume 70 (2021): Issue 3 (October 2021)

Previous article